The 5th annual OHDSI U.S. Symposium welcomed both veterans and new collaborators to the the Bethesda North Marriott Hotel & Conference Center on Sept. 16, 2019. The day opened with an introductory address and plenary talks surrounding real-world evidence, while the afternoon featured talks on community evidence in action and a closing talk on the 10-year history of the OMOP Common-Data Model and a challenge for the future of the OHDSI community.
The middle of the day featured the annual collaborator showcase, which included seven lightning talks, nearly 80 poster presentations and several software demos. The research highlights this year by OHDSI collaborators were inspirational, and you can find them all below on our virtual showcase page.
The talks will be uploaded to the OHDSI YouTube channel and linked here, and you will be able to find them with their presentation materials below. You can find continued updates about OHDSI on both our Twitter and LinkedIn pages as well.
Welcome to OHDSI 2019 (George Hripscak & Harlan Krumholz): Video • Slides
A journey toward real-world evidence for regulatory decision-making (Clair Blacketer & Andrew Williams): Video • Slides
Establishing scientific best practices for real-world analysis / Book of OHDSI: (Martijn Schuemie & David Madigan): Video • Slides
Proving reliable real-world evidence: Replicating RCTs using LEGEND (Patrick Ryan & George Hripcsak): Video • Slides
Stakeholder Panel: What has been done? Where should we go? How can we get there? (Moderator: Harlan Krumholz; Panel: Fatemah Alnofal (Research Specialist at the Saudi Food and Drug Authority), Joseph Ross (Professor of Internal Medicine at Yale University) and Azadeh Shoaibi (Lead of CBER Sentinel Program at US Food and Drug Administration): Video
Community Evidence In Action Talks
EHDEN/Oxford Study-A-Thon (Peter Rijnbeek & Dani Prieto-Alhambra): Video (coming soon) • Slides
CSS: Personalizing surgery for colorectal cancer (Ismail Gogenur & Gregory Klebanov): Video (coming soon) • Slides
Predicting breast cancer to improve screening (Women of OHDSI: Maura Beaton, Kristin Kostka, Jenna Reps & Anna Ostropolets): Video (coming soon) • Slides
Closing Session (Patrick Ryan & Christian Reich) – Coming Soon
Expanding OHDSI into Asia (Mui Van Zandt): Video (coming soon) • Slides
OMOP CDM Oncology Module at Work (Rimma Belenkaya): Video (coming soon) • Slides
FAIR Phenotyping with APHRODITE (Juan Banda): Video (coming soon) • Slides
OHDSI-enabled distributed network analysis for clinical trial feasibility: a collaborative case study to inform a pediatrics randomized trial (Rupa Makadia): Video (coming soon) • Slides
Comparing 102 psychotropic drug regimens for diabetes mellitus risk (Anastasiya Nestsiarovich): Video (coming soon) • Slides
Net Clinical Benefit of Ticagrelor compared to Clopidogrel in patients with Acute Coronary Syndrome following Percutaneous Coronary Intervention (Seng Chan You): Video (coming soon) • Slides
Delivering on-demand evidence via an informatics consultation service (Alison Callahan): Video (coming soon) • Slides
There were six tutorials held during the 2019 OHDSI Symposium weekend. All pertinent materials from these sessions are available below.
OMOP Common Data Model & Standardized Vocabularies
Patient-Level Prediction (PLP)
Faculty: Andrew Williams; Vojtech Huser, Ajit Londhe, Hanieh Razzaghi, Connor Callahan, Tim Bergquist
Video (coming soon) • Introduction Slides • DataQualityDashboard Slides • Testing Data Completeness with DQe-c-v2 Slides • PEDSnet Data Quality Slides • PEDSnet DQA Tutorial Slides
Extraction, Transformation, and Load Process (ETL)
Women of OHDSI Real-World Analytics Leadership Forum
The Women of OHDSI kicked off the weekend with a special event Sunday night, as they welcomed four leaders in the field to conduct the first Real-World Analytics Forum. The speakers were:
- Noémie Elhadad, PhD, Co-interim Chair, Associate Professor of Biomedical Informatics; Graduate Program Director at Columbia University
- Violanda Grigorescu, MD, MSPH, Chief, Partnerships and Evaluation Branch in the Center for Surveillance, Epidemiology and Laboratory Services at the Centers for Disease Control and Prevention
- Janet Woodcock, MD, Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration
- Joanne Waldstreicher, MD, Chief Medical Officer at Johnson & Johnson
You can see a recap of the great evening below.
OHDSI thanks all of its sponsors for their continued support of our mission improve health by empowering a community to collaboratively generate the evidence that promotes better health decisions and better care. You can see all our sponsors here.